Navigation Links
Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study
Date:6/26/2008

(BCVA) of 15 letters or greater from baseline. In addition, both the low dose and the high dose of Iluvien resulted in a significant reduction in retinal thickness as compared to the baseline.

From a safety perspective, no adverse events related to intraocular, or inner eye, pressure were seen in the low dose patients, while 12 percent of the high dose patients experienced intraocular pressure increases of greater than 30 mmHg. Additionally, the only adverse event related to cataract formation was reported in a patient in the high dose group.

The early readout from this PK Study provides further insight into the dose-response of FA in the treatment of DME. By comparison, Bausch & Lomb's Retisert(R) (fluocinolone acetonide intravitreal implant), with an initial release dose of 0.6 microgram per day, was also studied in a DME population. It demonstrated a significant improvement in visual acuity at one year, comparable to the Iluvien results reported here; however, a lower dose was not tested. Therefore, it has not been determined if Retisert's dosage level represents the lowest efficacious dose for DME.

"We believe this early readout from our PK Study supports our premise that lower doses of FA delivered by Iluvien will provide visual acuity improvements while reducing the risk of ocular side effects commonly associated with the use of corticosteroids," said Ken Green, Ph.D., chief scientific officer for Alimera.

Data from this open-label study will be evaluated on an ongoing basis with interim looks at months 3, 6, 12, 18, 24, 30 and 36. Except for the month 12 and final month 36 looks, when the database will be fully locked, interim evaluations will be based on unaudited data. The last patient was enrolled in this study at the end of February 2007.

About Alimera Sciences, Inc.

Alimera Sciences is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharma
'/>"/>

SOURCE Alimera Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , September 18, 2014 ... Markets ( http://www.researchandmarkets.com/research/f9nkkh/sugar_alcohols ) has announced the addition ... Business Report"  report to their offering.  ... analyzes the worldwide markets for Sugar Alcohols ... Segments: Food & Confectionery, Pharmaceuticals, Cosmetics, Oral-Care ...
(Date:9/18/2014)... , Sept. 18, 2014  LABSCO, ... laboratory technologies and products to hospitals, physician ... today an amended distributorship agreement with Sysmex ... controls and instruments, including the Sysmex XS-1000 ... XP-300™, XT-Series and XN-Series Automated Hematology Analyzers. ...
(Date:9/18/2014)... Sept. 18, 2014  PRO-DEX, INC. (NasdaqCM: PDEX) today ... and full-year ended June 30, 2014. ... months ended June 30, 2014 increased $492,000, or 18%, ... months ended June 30, 2013, due primarily to an ... revenues from the Company,s largest customer, partially offset by ...
Breaking Medicine Technology:Sugar Alcohols - Global Strategic Business Report 201 2Sugar Alcohols - Global Strategic Business Report 201 3LABSCO Renews Sysmex Distributorship Agreement 2LABSCO Renews Sysmex Distributorship Agreement 3Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 2Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 3Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 4Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 5Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 6Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 7Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 8Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 9Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 10Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 11Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 12Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 13
... Trial Marks Third Study in Company,s STEALTH C Clinical Program ... Nitazoxanide in the Treatment of Chronic Hepatitis C, ... company, today announced that it has begun enrolling,patients in a ... hepatitis C. Preliminary data from the study is,expected in the ...
... 17 BrainCells Inc. (BCI), a,biopharmaceutical company utilizing ... promote the growth of new neurons for the ... that it has,initiated a Phase 2a clinical trial ... of depression with anxiety., "We are encouraged ...
Cached Medicine Technology:Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 2Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 3BrainCells Inc. Initiates Phase 2 Clinical Trial with BCI-540 for Depression with Anxiety 2
(Date:9/18/2014)... 18, 2014 Ben Quirk, CEO of ... Jr. Leadership Award by the Savannah Science Seminar in ... wellness throughout the nation and especially in Savannah. , ... said Ben. “The Savannah Science Seminar is an amazing ... multiple generations have gone through the program,” he added. ...
(Date:9/18/2014)... to pay higher employee contributions for their health insurance, ... about the impact of the Patient Protection and Affordable ... by the Darla Moore School of Business at the ... Wright, a professor in strategic human resource management, directs ... The survey is distributed to more than 560 CHROs ...
(Date:9/18/2014)... 2014 ChopChop founder Sally Sampson ... Yonah Kalikow, 10-year-old Massachusetts’s winner of the First Lady’s Healthy ... the classic Middle Eastern bean dip. Watch as Bill and ... can create their own healthy dips at home. The cooking ... annual Let’s Talk About Food Festival in Copley ...
(Date:9/18/2014)... A sold-out crowd of more than ... supported United Way of Westchester and Putnam ... event Monday, Sept. 15. Proceeds from the event will ... and Putnam, such as providing healthy foods to low-income ... risky behaviors like drug and alcohol usage. , Two ...
(Date:9/18/2014)... broadly effective vaccines to prevent the spread of illnesses ... has been made along these lines, there are still ... from these devastating diseases. , So what are ... At Caltech, Nobel Laureate David Baltimore and his colleagues ... vaccines introduce substances such as antigens into the body ...
Breaking Medicine News(10 mins):Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Survey: Fortune 500 employees can expect to pay more for health insurance 2Health News:Survey: Fortune 500 employees can expect to pay more for health insurance 3Health News:Award-Winning Cooking Magazine for Kids Challenges Former White House Pastry Chef and 10-Year-Old Chef to Cook Up a Healthy Snack 2Health News:Award-Winning Cooking Magazine for Kids Challenges Former White House Pastry Chef and 10-Year-Old Chef to Cook Up a Healthy Snack 3Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 2Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 3Health News:A new way to prevent the spread of devastating diseases 2Health News:A new way to prevent the spread of devastating diseases 3Health News:A new way to prevent the spread of devastating diseases 4Health News:A new way to prevent the spread of devastating diseases 5
... Food and Drug Administration, seeking marketing authorization for Zometa ... broad range of tumor types. These include prostate and ... approved. The spread of cancerous cells from the original ... called skeletal related events like fractures, compression of ...
... more heart-friendly products has been developed by European scientists. ... UK and colleagues, describe how they boosted the production ... tomatoes. Rutin is a flavonol, part of a larger ... be a powerful antioxidant.// ,The researchers noticed ...
... As there is so much to do and remember ... uncommon. ,Many people find prolonged stress and ... and even personality changes. Dramatic alterations in memory and ... Alzheimer's disease. // ,The fundamental cause of dementia ...
... an infectious disease transmitted by mosquitoes.It is characterised by ... severe forms of this disease can lead to death ... countries.// ,Hence eradication of this disease involves the ... in southern Asia, villagers spray the inside of their ...
... with heart disease are more likely to have severe symptoms ... monthly menstrual cycle, according to new research from England. ... which occurs when there is insufficient oxygen supply to the ... of heart disease. Researchers from the Cardiothoracic Centre report in ...
... the US recommend that everyone over 65 should get a ... making you more prone to infection. That's why it may ... Mayo Clinic in the US also urge people over 65 ... you from pneumonia, meningitis, and various other serious infections. The ...
Cached Medicine News:
Smooth, round edges allow for safe manipulation within the eye. 1.1mm wide gradually tapers to .50 mm wide. 45, 1.1mm wide, gradually tapers to .50mm wide....
... has two perforations which enable ... various single or bilateral configurations ... drape has two perforations which ... to various single or bilateral ...
30, 6.0mm from end...
...
Medicine Products: